We are live on
!
Find out more
BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$13.5B
1-Year Est. Return
44.56%
This Fund
S&P 500
This Quarter
Est. Return
-1.5%
1 Year Est. Return
+44.56%
3 Year Est. Return
+147.62%
5 Year Est. Return
+116.32%
10 Year Est. Return
–
AUM
$11.3B
AUM Growth
+$2.15B
(+23%)
Cap. Flow
+$5.61B
Cap. Flow
% of AUM
49.58%
Top 10 Holdings %
Top 10 Hldgs %
40.26%
Holding
2,593
New
888
Increased
644
Reduced
565
Closed
479
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$887M |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$812M |
| 3 |
Microsoft
MSFT
|
+$670M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$516M |
| 5 |
NVIDIA
NVDA
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTKI
First Trust Small Cap BuyWrite Income ETF
FTKI
|
+$452M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$147M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$135M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$112M |
| 5 |
Walmart Inc
WMT
|
+$89.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.58% |
| 2 | Technology | 13.8% |
| 3 | Consumer Discretionary | 10.24% |
| 4 | Financials | 7.64% |
| 5 | Industrials | 5.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Eve Holding
EVEX
$805M
| $45.7K | ﹤0.01% |
+18,424
| New | +$62.9K |
|
2077
Telos
TLS
$358M
| $45.1K | ﹤0.01% |
10,762
-65,517
| -86% | -$310K |
|
2078
Playboy Inc
PLBY
$144M
| $44.9K | ﹤0.01% |
+29,550
| New | +$54K |
|
2079
Clover Health Investments
CLOV
$2.25B
| $44.5K | ﹤0.01% |
25,305
-124,203
| -83% | -$269K |
|
2080
Cibus
CBUS
$126M
| $44.5K | ﹤0.01% |
+22,473
| New | +$57.9K |
|
2081
Voyager Therapeutics
VYGR
$218M
| $43.9K | ﹤0.01% |
+11,365
| New | +$44.7K |
|
|
WHWK
2082
Whitehawk Therapeutics
WHWK
$263M
| $43.4K | ﹤0.01% |
+12,589
| New | +$39.4K |
|
2083
Village Farms International
VFF
$356M
| $43.4K | ﹤0.01% |
+15,290
| New | +$49.6K |
|
2084
Rezolute
RZLT
$445M
| $43.1K | ﹤0.01% |
+14,130
| New | +$42.4K |
|
2085
Ring Energy
REI
$378M
| $42.2K | ﹤0.01% |
+27,610
| New | +$35.1K |
|
2086
Aspen Aerogels
ASPN
$409M
| $39.7K | ﹤0.01% |
+11,619
| New | +$39.2K |
|
2087
NeoVolta
NEOV
$197M
| $38.5K | ﹤0.01% |
+12,510
| New | +$48.8K |
|
|
CNCK
2088
Coincheck Group
CNCK
$405M
| $38.1K | ﹤0.01% |
+25,764
| New | +$62.8K |
|
2089
Acumen Pharmaceuticals
ABOS
$211M
| $36.3K | ﹤0.01% |
+15,385
| New | +$39.2K |
|
2090
Akebia Therapeutics
AKBA
$243M
| $36.2K | ﹤0.01% |
26,021
-210,610
| -89% | -$289K |
|
2091
The Honest Company
HNST
$608M
| $36.1K | ﹤0.01% |
12,268
-11,967
| -49% | -$30.8K |
|
2092
Hyliion Holdings
HYLN
$627M
| $34.8K | ﹤0.01% |
19,793
-15,763
| -44% | -$31.7K |
|
2093
Maravai LifeSciences
MRVI
$1.14B
| $28.6K | ﹤0.01% |
+10,090
| New | +$34.2K |
|
|
ABTC
2094
American Bitcoin Corp
ABTC
$560M
| $27.6K | ﹤0.01% |
+1,988
| New | +$38.3K |
|
|
ELME
2095
Elme Communities
ELME
$149M
| $27.5K | ﹤0.01% |
13,674
-10,251
| -43% | -$33.8K |
|
|
EU
2096
enCore Energy
EU
$249M
| $22.3K | ﹤0.01% |
+12,337
| New | +$31.5K |
|
2097
Rani Therapeutics
RANI
$97M
| $17.1K | ﹤0.01% |
+23,336
| New | +$29.8K |
|
2098
Pacific Biosciences
PACB
$435M
| $14.3K | ﹤0.01% |
+10,806
| New | +$19.3K |
|
2099
BuzzFeed Inc Warrant
BZFDW
$670K
| $8.99K | ﹤0.01% |
603,324
| – | – |
|
2100
Advance Auto Parts
AAP
$2.59B
| – | – |
-5,395
| Closed | -$212K |
|
Similar funds
MGIA
PMAM
DWM
BGC
VIA
MSV
PFSRSONJ
Brevan Howard Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Brevan Howard Capital Management held 2,593 positions worth $11.3B, up 23% from $9.16B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Brevan Howard Capital Management deployed $5.61B of net new capital in Q1 2026, opening 888 new positions and adding to 644 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 6,420,000 shares worth $511M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 58% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $147M trimmed.
- Brevan Howard Capital Management's largest Q1 2026 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 6,420,000 shares worth $511M.
- Brevan Howard Capital Management added most to Invesco QQQ Trust in Q1 2026, an estimated $887M increase.
- Brevan Howard Capital Management's biggest Q1 2026 reduction was Alphabet (Google) Class A, cutting an estimated $147M.
- Brevan Howard Capital Management fully exited First Trust Small Cap BuyWrite Income ETF in Q1 2026, selling an estimated $452M.
- Brevan Howard Capital Management's ten largest holdings make up 40% of its $11.3B portfolio in Q1 2026.
- Brevan Howard Capital Management opened 888 new positions and closed 479 in Q1 2026.
- Brevan Howard Capital Management's portfolio value rose 23% quarter-over-quarter to $11.3B.
Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.